Manulife (Manufacturers Life Insurance)’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-60,051
| Closed | -$4.33M | – | 2901 |
|
|
2025
Q4 | $4.33M | Sell |
60,051
-205,758
| -77% | -$13.3M | ﹤0.01% | 1222 |
|
|
2025
Q3 | $11.6M | Buy |
265,809
+2,475
| +0.9% | +$100K | 0.01% | 792 |
|
|
2025
Q2 | $7.48M | Sell |
263,334
-1,179
| -0.4% | -$35.1K | 0.01% | 977 |
|
|
2025
Q1 | $7.81M | Buy |
264,513
+208
| +0.1% | +$6.48K | 0.01% | 958 |
|
|
2024
Q4 | $7.69M | Buy |
264,305
+6,849
| +3% | +$286K | 0.01% | 1014 |
|
|
2024
Q3 | $11.8M | Sell |
257,456
-15,306
| -6% | -$664K | 0.01% | 812 |
|
|
2024
Q2 | $11.1M | Buy |
272,762
+42,636
| +19% | +$1.22M | 0.01% | 794 |
|
|
2024
Q1 | $5.87M | Buy |
230,126
+71,519
| +45% | +$1.12M | 0.01% | 1118 |
|
|
2023
Q4 | $1.44M | Buy |
158,607
+16,343
| +11% | +$109K | ﹤0.01% | 1624 |
|
|
2023
Q3 | $908K | Sell |
142,264
-680
| -0.5% | -$5.86K | ﹤0.01% | 1789 |
|
|
2023
Q2 | $1.59M | Buy |
142,944
+7,005
| +5% | +$87.9K | ﹤0.01% | 1479 |
|
|
2023
Q1 | $2.09M | Buy |
135,939
+849
| +0.6% | +$18.7K | ﹤0.01% | 1389 |
|
|
2022
Q4 | $3.05M | Buy |
135,090
+43,622
| +48% | +$650K | ﹤0.01% | 1277 |
|
|
2022
Q3 | $1.52M | Sell |
91,468
-483
| -0.5% | -$9.24K | ﹤0.01% | 1455 |
|
|
2022
Q2 | $1.32M | Buy |
91,951
+9,835
| +12% | +$146K | ﹤0.01% | 1531 |
|
|
2022
Q1 | $1.49M | Buy |
82,116
+62,375
| +316% | +$1.06M | ﹤0.01% | 1584 |
|
|
2021
Q4 | $472 | Sell |
19,741
-26
| -0.1% | -$621 | ﹤0.01% | 2298 |
|
|
2021
Q3 | $487K | Buy |
19,767
+2,770
| +16% | +$60.2K | ﹤0.01% | 2308 |
|
|
2021
Q2 | $420K | Sell |
16,997
-24
| -0.1% | -$558 | ﹤0.01% | 2564 |
|
|
2021
Q1 | $371K | Buy |
17,021
+7,310
| +75% | +$179K | ﹤0.01% | 2477 |
|
|
2020
Q4 | $248K | Buy |
9,711
+823
| +9% | +$24K | ﹤0.01% | 2630 |
|
|
2020
Q3 | $250K | Buy |
+8,888
| New | +$257K | ﹤0.01% | 2421 |
|
Other funds holding RNAM
Manulife (Manufacturers Life Insurance)'s RNAM Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 60,051 shares — an estimated $4.33M sold.
Manulife (Manufacturers Life Insurance) first reported a position in RNAM in Q3 2020 and held it in 22 quarters. The position peaked at $11.8M in Q3 2024. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Manulife (Manufacturers Life Insurance) reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 60,051 Avidity Biosciences shares in Q1 2026, an estimated $4.33M.
- Manulife (Manufacturers Life Insurance) first reported a position in Avidity Biosciences in Q3 2020 and held it in 22 quarters.
- Manulife (Manufacturers Life Insurance)'s Avidity Biosciences position peaked at $11.8M in Q3 2024.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.